Literature DB >> 16873067

FOXP3 controls regulatory T cell function through cooperation with NFAT.

Yongqing Wu1, Madhuri Borde, Vigo Heissmeyer, Markus Feuerer, Ariya D Lapan, James C Stroud, Darren L Bates, Liang Guo, Aidong Han, Steven F Ziegler, Diane Mathis, Christophe Benoist, Lin Chen, Anjana Rao.   

Abstract

Antigen stimulation of immune cells activates the transcription factor NFAT, a key regulator of T cell activation and anergy. NFAT forms cooperative complexes with the AP-1 family of transcription factors and regulates T cell activation-associated genes. Here we show that regulatory T cell (Treg) function is mediated by an analogous cooperative complex of NFAT with the forkhead transcription factor FOXP3, a lineage specification factor for Tregs. The crystal structure of an NFAT:FOXP2:DNA complex reveals an extensive protein-protein interaction interface between NFAT and FOXP2. Structure-guided mutations of FOXP3, predicted to progressively disrupt its interaction with NFAT, interfere in a graded manner with the ability of FOXP3 to repress expression of the cytokine IL2, upregulate expression of the Treg markers CTLA4 and CD25, and confer suppressor function in a murine model of autoimmune diabetes. Thus by switching transcriptional partners, NFAT converts the acute T cell activation program into the suppressor program of Tregs.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16873067     DOI: 10.1016/j.cell.2006.05.042

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  491 in total

1.  IL-2 and IL-4 stimulate MEK1 expression and contribute to T cell resistance against suppression by TGF-beta and IL-10 in asthma.

Authors:  Qiaoling Liang; Lei Guo; Shaila Gogate; Zunayet Karim; Arezoo Hanifi; Donald Y Leung; Magdalena M Gorska; Rafeul Alam
Journal:  J Immunol       Date:  2010-10-06       Impact factor: 5.422

2.  Analysis of FoxP3+ T-regulatory cells and CD8+ T-cells in ovarian carcinoma: location and tumor infiltration patterns are key prognostic markers.

Authors:  Cecilia Hermans; David Anz; Jutta Engel; Thomas Kirchner; Stefan Endres; Doris Mayr
Journal:  PLoS One       Date:  2014-11-03       Impact factor: 3.240

3.  Identification of a tumor suppressor relay between the FOXP3 and the Hippo pathways in breast and prostate cancers.

Authors:  Weiquan Li; Lizhong Wang; Hiroto Katoh; Runhua Liu; Pan Zheng; Yang Liu
Journal:  Cancer Res       Date:  2011-01-28       Impact factor: 12.701

4.  Layers of regulation in induction of mixed chimerism by anti-CD40L.

Authors:  Carrie L Lucas; Megan Sykes
Journal:  Chimerism       Date:  2011 Oct-Dec

5.  Foxp1 Negatively Regulates T Follicular Helper Cell Differentiation and Germinal Center Responses by Controlling Cell Migration and CTLA-4.

Authors:  Bi Shi; Jianlin Geng; Yin-Hu Wang; Hairong Wei; Beth Walters; Wei Li; Xuerui Luo; Anna Stevens; Melanie Pittman; Bin Li; Sunnie R Thompson; Hui Hu
Journal:  J Immunol       Date:  2017-12-06       Impact factor: 5.422

Review 6.  Immune therapies.

Authors:  Rao H Prabhala; Nikhil C Munshi
Journal:  Hematol Oncol Clin North Am       Date:  2007-12       Impact factor: 3.722

Review 7.  Histone deacetylase inhibitors and transplantation.

Authors:  Ran Tao; Edwin F de Zoeten; Engin Ozkaynak; Liqing Wang; Bin Li; Mark I Greene; Andrew D Wells; Wayne W Hancock
Journal:  Curr Opin Immunol       Date:  2007-08-24       Impact factor: 7.486

8.  Melanoma induces immunosuppression by up-regulating FOXP3(+) regulatory T cells.

Authors:  Joel Baumgartner; Cara Wilson; Brent Palmer; Don Richter; Anirban Banerjee; Martin McCarter
Journal:  J Surg Res       Date:  2007-07       Impact factor: 2.192

9.  Regulation of MHC class I expression by Foxp3 and its effect on regulatory T cell function.

Authors:  Jie Mu; Xuguang Tai; Shankar S Iyer; Jocelyn D Weissman; Alfred Singer; Dinah S Singer
Journal:  J Immunol       Date:  2014-02-12       Impact factor: 5.422

Review 10.  Induction and stability of the anergic phenotype in T cells.

Authors:  Rut Valdor; Fernando Macian
Journal:  Semin Immunol       Date:  2013-11-05       Impact factor: 11.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.